Clinical trial for safety and tolerability using an interferon-inducible dendritic cell-based vaccine
Ontology highlight
ABSTRACT: Interventions: Dendritic cell-based cancer vaccination;Cancer, dendritic cell, vaccination
Primary outcome(s): Safety (adverse reactions, severe adverse events)
Study Design: single arm study,open(masking not used),uncontrolled control,single assignment
DISEASE(S): Breast Cancer, Colorectal Cancer, Pancreatic Cancer, Gastric Cancer, Lung Cancer
PROVIDER: 2613751 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA